UNSPSC 85252102: Diagnosis of malignant neoplasm on the central portion of breast

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Central portion of breast. Malignant neoplasm on the Central portion of breast is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C50. 1

UNSPSC 85252102 Diagnosis of malignant neoplasm on the central portion of breast is a Commodity code that shows a significant mismatch between its nominal scope and the actual state and local procurement activity it captures. The recent opportunities tagged to this code do not involve breast cancer diagnosis, oncology services, or medical testing related to malignant neoplasms. Instead, the opportunities cover diagnostic imaging system infrastructure (San Mateo Medical Center's PACS implementation), school district special education contracted services (Birdville Independent School District), and temporary health professional staffing across ancillary clinical categories (Santa Clara County Health System). These three solicitations span entirely different service lines — healthcare IT, education support services, and temporary clinical staffing — with no clear connection to breast cancer diagnosis or oncology work. The code appears to have been applied incorrectly to these opportunities or represents a classification error in the tagging process.

Given the absence of state and local solicitations actually seeking breast cancer diagnostic services, mammography interpretation, oncology consultation, or related medical services under this code in the recent opportunities block, the code shows little relevant activity for business development purposes. A firm pursuing diagnostic imaging, clinical staffing, or school-based special education services may encounter this code in procurement systems, but should not rely on it as a reliable signal for opportunities in those markets. The code warrants monitoring for future activity, but current procurement under 85252102 does not appear to reflect a stable or predictable demand signal for firms in oncology diagnosis, radiology interpretation, or related medical specialties.